ANRO vs BIIB: Which Stock is Better?
Side-by-side comparison of Alto Neuroscience Inc and Biogen Inc in 2026
ANRO
Alto Neuroscience Inc
$21.99
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ANRO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $644.94M | $27.13B | BIIB |
| P/E Ratio | N/A | 21.06 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze ANRO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANRO or BIIB a better investment?
Comparing ANRO and BIIB: Alto Neuroscience Inc has a market cap of $644.94M while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANRO and BIIB?
ANRO (Alto Neuroscience Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANRO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANRO or BIIB?
ANRO has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: ANRO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for ANRO.
Which is the larger company: ANRO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $644.94M for ANRO.
Should I buy ANRO or BIIB in 2026?
Both ANRO and BIIB have investment merit. ANRO trades at $21.99 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANRO and BIIB stock?
Key differences: Market Cap ($644.94M vs $27.13B), P/E Ratio (N/A vs 21.1x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).